Patented peptide-based nanodelivery platform that enhances cellular uptake of nucleic acid, protein and peptide therapeutics for cancer, hemophilia and metabolic/genetic disorders. Provides preclinical pharmaceutical development and commercialization partnerships with labs and pharma to offer a safer, more accurate alternative to existing delivery methods.